Inlyta 5mg-TU (Axitinib Tablet) 5mg

Axitinib 5mg tablets (Inlyta 5mg-TU) are a targeted therapy for advanced kidney cancer. This oral treatment helps manage disease progression with a convenient tablet form. Suitable for ambient storage, it offers a 56-tablet pack size. Axitinib 5mg is prescribed by doctors for specific cancer care needs.

Strength

5mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Axitinib 5mg tablets are used to treat advanced renal cell carcinoma, a type of kidney cancer. This targeted therapy helps slow disease progression in adults when other treatments are not suitable. It belongs to a class of medications that work by blocking certain signals in cancer cells. Patients may take axitinib 5mg as part of a broader cancer care plan.

Side Effects

Axitinib 5mg tablets may cause side effects such as diarrhea, high blood pressure, or fatigue. Some people experience nausea or decreased appetite while taking this medication. These effects vary by individual and should be monitored by a healthcare provider. Regular check-ups help manage any concerns during treatment.

Precautions & Warnings

Store axitinib 5mg tablets at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Do not crush, split, or chew the tablets unless advised by a doctor. Handle with care to avoid accidental exposure, especially if pregnant or breastfeeding.

Avoid Interactions

Axitinib may interact with other medications, including certain blood pressure drugs, antifungals, or antibiotics. Grapefruit products can affect how axitinib works, so avoid consuming them. Always inform your doctor about all prescriptions, over-the-counter drugs, and supplements you take. Alcohol use should be discussed with a healthcare provider.

Frequently Asked Questions

Axitinib 5mg tablets are prescribed to treat advanced kidney cancer in adults.

Store axitinib 5mg at room temperature in a dry place, away from direct light.

Axitinib can be taken with or without food, but consistency in timing is recommended.

Common side effects include diarrhea, high blood pressure, and fatigue.

No, axitinib is a targeted therapy, not a traditional chemotherapy medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.